Merck (MRK) reported Q2 FY 2017 earnings of $1.01 per share (versus $0.93 in Q2 FY 2016), beating analysts' consensus estimate of $0.87.
The company's quarterly revenues amounted to $9.930 bln (+0.9% y/y), beating analysts' consensus estimate of $9.746 bln.
MRK rose to $64.48 (+1.24%) in pre-market trading.